Clinical Trial Update: Cross-over Study of Coronary Risk Factors With a Polypill [Phase 4]

View source ↗

Summary

Phase 4 cross-over trial evaluating a polypill to modify coronary risk factors in patients with coronary artery disease. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Polypill

Snippet

Sponsor: Fundación EPIC | Conditions: Coronary Artery Disease | Phase 4 | Status: RECRUITING